Skip to content
Get alerts
GovInfoNow
Stop using now Drug recall · FDA · Published February 21, 2019

Recall: Professional Compounding Pharmacy Sterile Injectable Drug

Professional Compounding Pharmacy recalls a sterile injectable drug due to insanitary compounding conditions. Check lot numbers and distribution details.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-1110-2019DrugProfessional Compounding Pharmacy ›
Take action

Contact the company

Recalling firmHealth Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy996 Nw Circle Blvd Ste 105 · Corvallis, OR 97330-1485
✎ GovInfoNow plain-language explainer

Health Solutions Pharmacy Center Inc, doing business as Professional Compounding Pharmacy, is recalling one prescription of Papaiverine-Phentolamine-PGE1 17.44-0.64MG-5.8MCG/ML* injectable solution. The recall was initiated because the FDA observed insanitary conditions during the compounding of this sterile drug in their Corvallis, Oregon facility. This lack of processing controls poses a risk of contamination to patients receiving the medication. Read more at govinfonow.com/recall/39158-recall-professional-compounding-pharmacy-sterile-injectable-drug.

Source Summary by GovInfoNow · govinfonow.com/recall/39158-recall-professional-compounding-pharmacy-sterile-injectable-drug · Updated October 11, 2026 · FDA enforcement record: FDA #D-1110-2019

Cite this page

“Recall: Professional Compounding Pharmacy Sterile Injectable Drug.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/39158-recall-professional-compounding-pharmacy-sterile-injectable-drug. Based on FDA recall #D-1110-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1110-2019%22&limit=1).

The Food and Drug Administration announced on Feb. 21, 2019, that Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy voluntarily recalled Papaiverine-Phentolamine-PGE1 Injectable due to insanitary conditions observed during compounding. The agency classified the recall as Class II.

How to tell if you have it

  • Brand: Professional Compounding Pharmacy
  • Product: PAPAVERINE-PHENTOLAMINE-PGE1 17.44-0.64MG-5.8MCG/ML* INJECTABLE, 5 ml
  • Lot code: 13092018@44
  • Distribution: Dispensed in Oregon between Sept. 1, 2018, and Feb. 20, 2019

The hazard

The recall addresses a lack of processing controls resulting from insanitary conditions observed during the compounding of sterile drugs during a recent FDA inspection.

Context

GovInfoNow's records show other recent recalls of similar products include Carolina Infusion Recalls Quad-Mix Injectable Due to Sterility Risk (Sept. 10, 2026) and American Regent Papaverine HCl Injection Recall: Particulate Matter Hazard (July 24, 2026). Shoolin Pharma Chem Sildenafil Recall: FDA Inspection Findings was also reported on Aug. 3, 2026.

How to tell if you have this one

Check if you have a prescription for Papaiverine-Phentolamine-PGE1 17.44-0.64MG-5.8MCG/ML* injectable, 5 ml. Verify the lot number is 13092018@44. The product was dispensed in Oregon during the period from September 1, 2018, to February 20, 2019.

  • Brand
    Professional Compounding Pharmacy
  • Category
    Drug
FDA recall event · 25 products

All 25 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Dispensed in Oregon
Recall numberProduct, codes & lotsQuantity
D-1086-2019SODIUM CHLORIDE PRES-FREE 5% OPHTH STERILE* SOLUTION. 20ml eye drops, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330; Lot: 12022019@30, distributed between 09-01-2018 to 02-20-2019.1 prescription 20ml solution
D-1087-2019DEXAMETHASONE (NAPO4) 0.1% OPHTH* PRES-FREE SOLUTION, 10ml, Eye Drops, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330; Lots: 23012019@48, 24012019@2, 24012019@36, 28012019@35, 29012019@13, 05022019@5, 11022019@13, 12022019@20, 19022019@1, 19022019@6, 19022019@57, 19022019@61, All lots within expiry distributed between 09-01-2018 to 02-20-2019.12 prescriptions
D-1088-2019ACETYL-L-CYSTEINE 10% P.F. OPHTH SOLUTION, 10ml, eye drops, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330; Lots: 17012019@13, 30012019@36, 01022019@4, 14022019@1, 19022019@18, 19022019@60, distributed between 09-01-2018 to 02-20-2019.6 prescriptions 10ml dropper bottle
D-1089-2019HYDROXYPROGESTERONE CAPROATE 250 MG/ML OIL* INJECTABLE, (a) 10ml (b) 9ml injectable, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .; Lots: (a) 01112018@19, 04012019@52, 14022019@23, (b) 14012019@36, distributed between 09-01-2018 to 02-20-2019.4 prescriptions 9 & 10ml injectable
D-1090-2019PAPAVERINE-PHENTOLAMINE-PGE1 22-0.8 MG-8 MCG/ML* INJECTABLE, (a) 5ml (b) 10ml, (c) 6ml, penile injection, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330; Lot: (a) 18092018@52, 01102018@9, 05102018@36, 08102018@11, 102018@9, 01102018@9, 01102018@9, 03102018@27, 12102018@18, 01102018@9, 12102018@18, 12102018@18, 17102018@15, 12102018@18, 2102018@18, 22102018@31, 30102018@22, 29102018@9,29102018@9 29102018@9, 29102018@9, 12102018@18, 21112018@38, 21112018@38, 21112018@38, 21112018@38, 21112018@38, 21112018@38, 11122018@7, 11122018@7, 28122018@11, 28122018@11, 28122018@11, 03012019@17, 03012019@17, 03012019@17, 08012019@21, 08012019@21,28082018@16 28082018@16, 28082018@16, 14092018@28, 14092018@28, 4092018@28, 14092018@28, 18092018@52, 18092018@52, 8092018@52, 18092018@52, 18092018@52, (b) 29102018@9, 03012019@17,14092018@28, (c) 11012019@64, 11012019@64, 11012019@64, 05022019@27, 5022019@27, 06022019@6, 06022019@6, distributed between 09-01-2018 to 02-20-2019.64 prescriptions 5, 10, 6 mL injections
D-1091-2019PGE1 40 MCG/ML* INJECTABLE, (2) 5ml (b) 10ml, (c) 6ml (d) 9ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .; Lot:(a) 10102018@30, (b) 31102018@33,05112018@1, (c)15012019@8, (d) 30012019@33, distributed between 09-01-2018 to 02-20-2019.5 prescriptions 5,10, 6, 9 ml injectable
D-1092-2019PAPAVERINE-PHENTOLAMINE 30-1 MG/ML* INJECTABLE, (a)10ml (b) 9ml, penile injection, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330; Lot:(a) 08102018@11, 27122018@33, (b) 30012019@43, distributed between 09-01-2018 to 02-20-2019.3 prescriptions 10, 9, ml injection
D-1093-2019PAPAVERINE-PHENTOLAMINE-PGE1 30-1 MG-10 MCG/ML* INJECTABLE, (a) 5ml, (b) 6ml, (c) 9ml (d) 10ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330; Lot: (a) 03102018@27, 07112018@18, 08112018@11, 16112018@15, 28112018@7, 14122018@37,16112018@41, 03012019@9, (b) 2012019@32, 23012019@59, (c)07022019@19, 07022019@1, (d)19122018@25, distributed between 09-01-2018 to 02-20-2019.13 prescription 5, 6, 9, 10 ml injection
D-1094-2019PAPAVERINE-PHENTOLAMINE-PGE1 12-1MG-10MCG/ML INJECTABLE, (a) 10ml, (b) 9ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330; Lot (a)17102018@15,14112018@3, 04122018@21, 14122018@15, 7122018@11, 28122018@69, 20092018@2, (b) 21012019@37, 22012019@31, distributed between 09-01-2018 to 02-20-2019.9 prescriptions 10, 9ml injection
D-1095-2019PAPAVERINE-PHENTOLAMINE-PGE1 17.16-0.57MG-19.45MCG/ML* INJECTABLE, 5ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330; Lot 30102018@22, 15112018@5, distributed between 09-01-2018 to 02-20-2019.2 prescription 5ml injection
D-1096-2019PAPAVERINE-PHENTOLAMINE-PGE1 23-0.96MG-19.2MCG/ML INJECTABLE, (a) 5ml, (b) 6.5ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330; Lot: (a) 22102018@31, (b) 09112018@33, distributed between 09-01-2018 to 02-20-2019.2 prescription 5, 6.5 ml injection
D-1097-2019PAPAVERINE-PHENTOLAMINE-PGE1 30-1.6 MG-16 MCG/ML* INJECTABLE, (a) 5ml, (b) 10ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .; Lot: 05102018@36,27112018@49, (b) 28112018@54, distributed between 09-01-2018 to 02-20-2019.3 prescription 5, 10 ml injection
D-1098-2019PGE1-LIDOCAINE 40 MCG-1% /ML* INJECTABLE, (a) 10 ml (b) 9ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .; Lot:(a) 26092018@22, 26092018@22, 09102018@47, 15102018@33, 15102018@33, 09102018@47, 15102018@33, 09102018@47, 29112018@4, 10122018@14, 29112018@4, 29112018@4, 19122018@20, 21122018@29, 21122018@29, 27122018@20, (b) 16012019@59, 18012019@17, 21012019@49, 21012019@49, 22012019@24, 22012019@24, distributed between 09-01-2018 to 02-20-2019.25 prescriptions 10, 9, ml injectable
D-1099-2019PAPAVERINE-PHENTOLAMINE 15-0.5MGMG/ML INJECTABLE, 9ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .; Lot:15012019@10, distributed between 09-01-2018 to 02-20-2019.1 prescription 9ml injectable
D-1100-2019PAPAVERINE-PHENTOLAMINE 30-0.5 MG/ML INJECTABLE, 9ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .; Lot:19022019@21, distributed between 09-01-2018 to 02-20-2019.1 prescription, 9ml injectable
D-1101-2019PAPAVERINE-PHENTOLAMINE-PGE1 30-2 MG-30 MCG/ML* INJECTABLE, 5ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .; Lot:15112018@40 , distributed between 09-01-2018 to 02-20-2019.1 prescription, 5ml injectable
D-1102-2019PAPAVERINE-PHENTOLAMINE-PGE1 15-0.5MG-10MCG/ML INJECTABLE, 9ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .; Lot:17012019@27, distributed between 09-01-2018 to 02-20-2019.1 prescription, 9ml injection
D-1103-2019PAPAVERINE-PHENTOLAMINE-PGE1 16.6-0.55 MG-11.1 MCG/ML* INJECTABLE, 10 ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .; Lot:09112018@55, 09012019@37, distributed between 09-01-2018 to 02-20-2019.2 pre4scriptions 10 ml injections
D-1104-2019PAPAVERINE-PHENTOLAMINE-PGE1 17.64-0.58MG-5.88MCG/ML* INJECTABLE, 9 ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .; Lot:17012019@18, distributed between 09-01-2018 to 02-20-2019.1 prescription 9ml injection
D-1105-2019PAPAVERINE-PHENTOLAMINE-PGE1 22.5-0.8MG-8.3MCG/ML INJECTABLE, 5 ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .; Lot:26112018@68, 13122018@12, distributed between 09-01-2018 to 02-20-2019.2 prescriptions, 5ml injection
D-1106-2019PAPAVERINE-PHENTOLAMINE-PGE1 9-1 MG-10 MCG/ML* INJECTABLE, 18 ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .; Lot:12022019@23, distributed between 09-01-2018 to 02-20-2019.1 prescription, 18ml injection
D-1107-2019PAPAVERINE-PHENTOLAMINE-PGE1 30-1 MG-20 MCG/ML* INJECTABLE, 5 ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .; Lot:20092018@41, 25092018@7, 27092018@3, distributed between 09-01-2018 to 02-20-2019.3 prescriptions, 5ml injectable
D-1108-2019PAPAVERINE-PHENTOLAMINE-PGE1 15-0.25MG-6MCG/ML INJECTABLE, 5 ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .; Lot:06092018@57, distributed between 09-01-2018 to 02-20-2019.1 prescription, 5ml injection
D-1109-2019PAPAVERINE-PHENTOLAMINE-PGE1 17.44-0.58MG-5.8MCG/ML* INJECTABLE, 5 ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .; Lot:19092018@1, distributed between 09-01-2018 to 02-20-2019.1 prescription, 5ml
D-1110-2019PAPAVERINE-PHENTOLAMINE-PGE1 17.44-0.64MG-5.8MCG/ML* INJECTABLE, 5 ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .; Lot:13092018@44, distributed between 09-01-2018 to 02-20-2019.1 prescription, 5ml injection
Based on the official FDA remedy

What to do — step by step

  1. Stop using the medication

    Do not use the recalled injectable solution due to potential contamination risks.

  2. Contact your pharmacy

    Reach out to Professional Compounding Pharmacy in Corvallis, Oregon, for further instructions on disposal or replacement.

Where it went and when

Where it was distributed

Distributed in Oregon.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: yesORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “Dispensed in Oregon” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Oregon.

Recall timeline

FDA terminated this recall 17 months after the firm started it.

1. Firm started the recall: Feb 21, 201912. FDA classified it Class II: Apr 9, 201923. Published in FDA’s Enforcement Report: Apr 17, 201934. FDA terminated the recall: Jul 23, 2020420192020
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Preferred Pharma Recalls Lidocaine Ointment Due to Content Issues
Preferred Pharmaceuticals, Inc.Northstar Rx Recalls Tretinoin Cream Due to Impurities
SUN PHARMACEUTICAL INDUSTRIES INCApothecary Pharma Recalls Tirzepatide Injections Due to Sterility Risk
Apothecary Pharma LLCApotex Recalls Paroxetine 37.5mg Due to Dissolution Failure
Apotex Corp.Cipla Recalls Fosfomycin Tromethamine Granules Due to Impurities
Cipla USA, Inc.

Latest drug recalls

Ajanta Pharma USA Inc recalls Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc.,
Ajanta Pharma · September 17, 2026Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company recalls Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with
Insight Pharmaceuticals · September 15, 2026K.C. Pharmaceuticals, Inc. recalls Sterile Lubricant Dry Eye Relief Eye Drops, 0.5 FL OZ (15 mL); a) LEADER, DISTRIBUTED BY CARDINAL HEALTH, DUBLIN, OHIO
Leader / TopCare / Crocodile Tears · September 11, 2026Amneal Pharmaceuticals, LLC recalls Estradiol Gel, 0.1%, 0.25 mg, 30-packets per carton, Rx only, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater,
Amneal Pharmaceuticals · September 8, 2026Inventia Healthcare Limited recalls Chlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Manufactured by: Inventia Healthcare Limited. NDC:
Inventia Healthcare · September 3, 2026SV Labs Toronto Corporation recalls Benzoyl Peroxide Wash, USP, 10%, packaged in a)5 FL OZ (148mL) bottles (NDC 0536-1261-63), and b) 8.5 FL OZ (237 mL)
SV Labs · September 1, 2026

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1110-2019 (February 21, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1110-2019 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA